|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-8-7
|
|
pubmed:abstractText |
Interferon beta (IFNbeta) preparations have some effect on the progressive phase of multiple sclerosis (MS). This limited effect might be partially because of a certain number of IFNbeta non-responders. Myxovirus resistance protein A (MxA)--a marker of IFNbeta bioactivity--was correlated with the clinical response during an uncontrolled trial, investigating the safety of IFNbeta-1b in primary progressive (PPMS) patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1468-1331
|
|
pubmed:author |
pubmed-author:BahnerDD,
pubmed-author:BitschAA,
pubmed-author:BogumilTT,
pubmed-author:DeisenhammerFF,
pubmed-author:DresselAA,
pubmed-author:ElitokEE,
pubmed-author:GneissCC,
pubmed-author:KitzeBB,
pubmed-author:MillonigAA,
pubmed-author:TumaniHH,
pubmed-author:WeberFF
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
822-6
|
|
pubmed:meshHeading |
pubmed-meshheading:18549400-Adjuvants, Immunologic,
pubmed-meshheading:18549400-Adolescent,
pubmed-meshheading:18549400-Adult,
pubmed-meshheading:18549400-Area Under Curve,
pubmed-meshheading:18549400-Biological Markers,
pubmed-meshheading:18549400-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:18549400-Female,
pubmed-meshheading:18549400-GTP-Binding Proteins,
pubmed-meshheading:18549400-Humans,
pubmed-meshheading:18549400-Interferon-beta,
pubmed-meshheading:18549400-Male,
pubmed-meshheading:18549400-Middle Aged,
pubmed-meshheading:18549400-Multiple Sclerosis, Chronic Progressive
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients.
|
|
pubmed:affiliation |
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
